Can Oral Bisphosphonates Really Reduce the Risk of Breast Cancer in Healthy Women?-Reference-Cited by-同舟云学术

Can Oral Bisphosphonates Really Reduce the Risk of Breast Cancer in Healthy Women?

Published:2010-08-01 Issue:22 Volume:28 Page:3548-3551
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Gnant Michael¹

Affiliation:

1. Medical University of Vienna, Vienna, Austria

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.29.6327

Reference34 articles.

1. Clinician's Guide to Prevention and Treatment of Osteoporosis 1– 36,2010 National Osteoporosis Foundation Washington, DC National Osteoporosis Foundation

2. Prevention and management of osteoporosis—WHO Technical Report Series 921 1– 192,2003 World Health Organization Geneva, Switzerland World Health Organization

3. Postmenopausal Osteoporosis

4. Hormone replacement therapy and cardiovascular disease revisited

5. Prescribing Information Boniva http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021858s001lbl.pdf

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphosphonates pharmacology and use in the treatment of osteoporosis;Marcus and Feldman's Osteoporosis;2021

2. Zoledronic acid boosts γδ T-cell activity in children receiving αβ+T and CD19+cell-depleted grafts from an HLA-haplo-identical donor;OncoImmunology;2017-01-31

3. Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case–control studies using two primary-care databases;British Journal of Cancer;2013-07-18

4. Essential Requirements of Zoledronate-Induced Cytokine and γδ T Cell Proliferative Responses;The Journal of Immunology;2013-06-21

5. Regulation of mevalonate metabolism in cancer and immune cells;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2013-06